These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8957437)
1. Reduction in requirements for allogeneic blood products: nonpharmacologic methods. Hardy JF; Bélisle S; Janvier G; Samama M Ann Thorac Surg; 1996 Dec; 62(6):1935-43. PubMed ID: 8957437 [TBL] [Abstract][Full Text] [Related]
2. [Bleeding problems in open heart surgery]. Lutter G; Beyersdorf F Chirurg; 2000 Apr; 71(4):369-73. PubMed ID: 10840603 [TBL] [Abstract][Full Text] [Related]
3. Autologous versus allogeneic transfusion: patients' perceptions and experiences. Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337 [TBL] [Abstract][Full Text] [Related]
4. Transfusion medicine : support of patients undergoing cardiac surgery. Goodnough LT; Despotis GJ Am J Cardiovasc Drugs; 2001; 1(5):337-51. PubMed ID: 14728016 [TBL] [Abstract][Full Text] [Related]
5. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. Dupuis JY; Bart B; Bryson G; Robblee J CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338 [TBL] [Abstract][Full Text] [Related]
6. Non-pharmacological strategies for blood conservation in cardiac surgery. Ruel MA; Rubens FD Can J Anaesth; 2001 Apr; 48(4 Suppl):S13-23. PubMed ID: 11336432 [TBL] [Abstract][Full Text] [Related]
7. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. ; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454 [TBL] [Abstract][Full Text] [Related]
8. Blood conservation operations in pediatric cardiac patients: a paradigm shift of blood use. Karimi M; Florentino-Pineda I; Weatherred T; Qadeer A; Rosenberg CA; Hudacko A; Ryu D Ann Thorac Surg; 2013 Mar; 95(3):962-7. PubMed ID: 23201105 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
10. Shed mediastinal blood transfusion after cardiac operations: a cost-effectiveness analysis. Kilgore ML; Pacifico AD Ann Thorac Surg; 1998 May; 65(5):1248-54. PubMed ID: 9594846 [TBL] [Abstract][Full Text] [Related]
11. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Moonen AF; Knoors NT; van Os JJ; Verburg AD; Pilot P Transfusion; 2007 Mar; 47(3):379-84. PubMed ID: 17319816 [TBL] [Abstract][Full Text] [Related]
12. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329 [TBL] [Abstract][Full Text] [Related]